Su San Lee | Unsplash


Japan is a key strategic partner for Europe, and the bilateral research and innovation relations have developed steadily over the past two decades. The agreement on cooperation entered into force in 2011. The programme’s primary objectives are to enhance research excellence and boost growth and industrial competitiveness. A Letter of Intent was signed by both parties in May 2020 to reinforce collaboration in science, technology and innovation, and to optimise the interplay between Horizon Europe and Moonshot, Japan’s research and development programme. The agreement will facilitate collaboration between researchers and innovators on global challenges such as health, climate change, digital transition and ageing societies, as well as the fight against the coronavirus pandemic. This will be achieved through open access to research data and results.

With regard to the countries’ participation in the Marie Skłodowska-Curie Actions (MSCA), approximately half of the MSCA projects with Japanese participation are in the fields of natural sciences, engineering and technology, and social sciences. Japan has traditionally been strong in these three broad fields, which reflect mutual strategic priorities with the EU. There is a significant imbalance in the number of inbound and outbound researchers through the MSCA between Japan and the EU and associated countries. Japan receives a larger number of researchers than it sends abroad.

For more detailed information on the Japanese R&I landscape and MSCA participation, check out the documents below.

Click to download the PDFs:

Japan factsheet Marie Skłodowska-Curie Actions

Japan R&I cooperation status: Key facts and figures

MSCA promotion landscape: Key promotion players and potential: Japan, plan 1

MSCA promotion landscape: Key promotion players and potential: Japan, plan 2